Is a complete GTBP research report available?

No complete published report is available for GT Biopharma, Inc. (GTBP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

GT Biopharma, Inc. (GTBP)

NASDAQ: GTBP · USD

$5.61

+0.03 (+0.5%)· Recorded snapshot

Market cap	10.1M
Net income (ttm)	-11.4M
EPS (ttm)	-$13.2
Shares out	1.8M
Volume	53,116
Beta	0.86

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.4M
EPS (ttm): -$13.2
Market cap: 10.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0000109657
Company name	GT Biopharma, Inc.
Country	United States
Country code	US
CUSIP number	36254L407
Earnings date	2026-11-13
Earnings time	bmo
Employees	1
Employees change	-1
Employees growth	-50%
Enterprise value	$5.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1965
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US36254L4077
Last 10-K release date	2026-03-02
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-09-08
Last stock split type	Reverse
Market cap	$10.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$5.61
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GTBP
U.S. state	California
Website	https://www.gtbiopharma.com

Metric

Value

Amount currency

USD

CIK code

0000109657

Company name

GT Biopharma, Inc.

Country

United States

Country code

CUSIP number

36254L407

Earnings date

2026-11-13

Earnings time

bmo

Employees

Employees change

-1

Employees growth

-50%

Enterprise value

$5.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1965

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US36254L4077

Last 10-K release date

2026-03-02

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2026-09-08

Last stock split type

Reverse

Market cap

$10.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Price

$5.61

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GTBP

U.S. state

California

Website

https://www.gtbiopharma.com

Metric	Value
Earnings yield	-235.64%
FCF / EV yield	-292.74%
FCF yield	-145.89%
P/B ratio	2.79x
Price / tangible book value	2.77x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-235.64%

FCF / EV yield

-292.74%

FCF yield

-145.89%

P/B ratio

2.79x

Price / tangible book value

2.77x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-11.4M
ROA	-158.16%
ROA (5Y)	-104.63%
ROCE	-457.75%
ROE	-113.52%
ROIC	-243.52%

Metric

Value

Profit per employee

$-11.4M

ROA

-158.16%

ROA (5Y)

-104.63%

ROCE

-457.75%

ROE

-113.52%

ROIC

-243.52%

Metric	Value
EPS growth quarters	2
EPS growth years	1
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
EBIT	$-16.3M
EPS	$-13.22
FCF per share	$-7.99
Financing cash flow	$14.2M
Free cash flow	$-14.4M
Free cash flow minus SBC	$-14.9M
Net cash flow	$-267,000
Net income	$-11.4M
Operating cash flow minus SBC	$-14.9M
Operating income	$-16.3M
Stock-based compensation	$517,000

Metric

Value

EBIT

$-16.3M

EPS

$-13.22

FCF per share

$-7.99

Financing cash flow

$14.2M

Free cash flow

$-14.4M

Free cash flow minus SBC

$-14.9M

Net cash flow

$-267,000

Net income

$-11.4M

Operating cash flow minus SBC

$-14.9M

Operating income

$-16.3M

Stock-based compensation

$517,000

Metric	Value
Book value per share	$2.00
Debt / equity	0
Interest coverage	-64.32
Long-term assets	$0
Long-term liabilities	$0
Net cash (debt)	$5M
Net cash / market cap	50.16%
Net cash growth	-5.13%
Net debt / equity	-1.39
Piotroski F-Score	0
Shareholders' equity	$3.6M
Tangible book value	$3.6M
Tangible book value per share	$2.00
Total assets	$5.8M
Total cash	$5M
Total debt	$0
Total liabilities	$2.2M
WACC	8.95%

Metric

Value

Book value per share

$2.00

Debt / equity

Interest coverage

-64.32

Long-term assets

Long-term liabilities

Net cash (debt)

$5M

Net cash / market cap

50.16%

Net cash growth

-5.13%

Net debt / equity

-1.39

Piotroski F-Score

Shareholders' equity

$3.6M

Tangible book value

$3.6M

Tangible book value per share

$2.00

Total assets

$5.8M

Total cash

$5M

Total debt

Total liabilities

$2.2M

WACC

8.95%

Metric	Value
Current assets	$5.8M
Current liabilities	$2.2M
Current ratio	2.61
Net working capital	$-1.4M
Quick ratio	2.24
Working capital	$3.6M

Metric

Value

Current assets

$5.8M

Current liabilities

$2.2M

Current ratio

2.61

Net working capital

$-1.4M

Quick ratio

2.24

Working capital

$3.6M

Metric	Value
Buyback yield / dilution	-795.21%
Dividend yield	0%
Shareholder yield	-795.21%

Metric

Value

Buyback yield / dilution

-795.21%

Dividend yield

Shareholder yield

-795.21%

Metric	Value
10Y price change	-100%
10Y return CAGR	-68.42%
10Y total return	-100%
150-day SMA	$8.75
15Y price change	-100%
15Y return CAGR	-65.59%
15Y total return	-100%
1D price change	0.54%
1M price change	-18.43%
1M total return	-18.43%
1W price change	-23.12%
1W total return	-23.12%
1Y price change	-67.63%
1Y return CAGR	-67.65%
1Y total return	-67.63%
20-day SMA	$6.21
200-day SMA	$9.86
20Y price change	-100%
20Y return CAGR	-58.03%
20Y total return	-100%
3M price change	-32.72%
3M total return	-32.71%
3Y price change	-97.06%
3Y return CAGR	-69.13%
3Y total return	-97.06%
50-day SMA	$6.83
50-day SMA vs 200-day SMA	50under200
52-week high	$28.75
52-week high date	2025-11-14
52-week low	$4.91
52-week low date	2026-09-08
5Y price change	-99.88%
5Y return CAGR	-73.92%
5Y total return	-99.88%
6M price change	-19.69%
6M total return	-19.69%
All-time high	$42,500,000,000.00
All-time high date	1991-11-08
All-time low	$4.91
All-time low date	2026-09-08
Average true range (ATR)	$0.73
Average volume	59.9K
Beta (1Y)	1.66
Beta (2Y)	0.65
Beta (5Y)	0.86
Change from 52-week high	-80.49%
Change from 52-week low	14.26%
Change from all-time high	-100%
Change from all-time low	14.46%
Change from open	2.94%
Day's gap	-2.33%
Dollar volume	$297,981
High price	$5.66
Low price	$5.45
Monthly RSI	37.12
Open price	$5.45
Position in 52-week range	76.19%
Premarket change	0%
Premarket close	$5.58
Premarket price	$5.58
Previous close	$5.58
Price vs 150-day SMA	-35.77%
Price vs 20-day SMA	-9.52%
Price vs 200-day SMA	-43%
Price vs 50-day SMA	-17.67%
Relative volume	0.89
RSI	43.46
Sharpe ratio	-0.32
Sharpe ratio (3Y)	-0.28
Sharpe ratio (5Y)	-0.59
Sortino ratio	-0.45
Sortino ratio (3Y)	-0.47
Sortino ratio (5Y)	-0.98
Volume	53.1K
Weekly RSI	36.65
YTD price change	-71.37%
YTD total return	-71.37%

Metric

Value

10Y price change

-100%

10Y return CAGR

-68.42%

10Y total return

-100%

150-day SMA

$8.75

15Y price change

-100%

15Y return CAGR

-65.59%

15Y total return

-100%

1D price change

0.54%

1M price change

-18.43%

1M total return

-18.43%

1W price change

-23.12%

1W total return

-23.12%

1Y price change

-67.63%

1Y return CAGR

-67.65%

1Y total return

-67.63%

20-day SMA

$6.21

200-day SMA

$9.86

20Y price change

-100%

20Y return CAGR

-58.03%

20Y total return

-100%

3M price change

-32.72%

3M total return

-32.71%

3Y price change

-97.06%

3Y return CAGR

-69.13%

3Y total return

-97.06%

50-day SMA

$6.83

50-day SMA vs 200-day SMA

50under200

52-week high

$28.75

52-week high date

2025-11-14

52-week low

$4.91

52-week low date

2026-09-08

5Y price change

-99.88%

5Y return CAGR

-73.92%

5Y total return

-99.88%

6M price change

-19.69%

6M total return

-19.69%

All-time high

$42,500,000,000.00

All-time high date

1991-11-08

All-time low

$4.91

All-time low date

2026-09-08

Average true range (ATR)

$0.73

Average volume

59.9K

Beta (1Y)

1.66

Beta (2Y)

0.65

Beta (5Y)

0.86

Change from 52-week high

-80.49%

Change from 52-week low

14.26%

Change from all-time high

-100%

Change from all-time low

14.46%

Change from open

2.94%

Day's gap

-2.33%

Dollar volume

$297,981

High price

$5.66

Low price

$5.45

Monthly RSI

37.12

Open price

$5.45

Position in 52-week range

76.19%

Premarket change

Premarket close

$5.58

Premarket price

$5.58

Previous close

$5.58

Price vs 150-day SMA

-35.77%

Price vs 20-day SMA

-9.52%

Price vs 200-day SMA

-43%

Price vs 50-day SMA

-17.67%

Relative volume

0.89

RSI

43.46

Sharpe ratio

-0.32

Sharpe ratio (3Y)

-0.28

Sharpe ratio (5Y)

-0.59

Sortino ratio

-0.45

Sortino ratio (3Y)

-0.47

Sortino ratio (5Y)

-0.98

Volume

53.1K

Weekly RSI

36.65

YTD price change

-71.37%

YTD total return

-71.37%

Metric	Value
Float	1.7M
Float percentage	93.91%
Shares change (QoQ)	28.19%
Shares change (YoY)	795.21%
Shares held by insiders	6.09%
Shares held by institutions	14.01%
Shares outstanding	1.8M
Short % of float	16.45%
Short % of shares	15.45%
Short ratio	2.2 days

Metric

Value

Float

1.7M

Float percentage

93.91%

Shares change (QoQ)

28.19%

Shares change (YoY)

795.21%

Shares held by insiders

6.09%

Shares held by institutions

14.01%

Shares outstanding

1.8M

Short % of float

16.45%

Short % of shares

15.45%

Short ratio

2.2 days

GT Biopharma, Inc. (GTBP)

Price

Financial snapshot

Fair-value bridge

Latest news · GTBP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GTBP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GTBP

Frequently asked questions